1995 Results

People

  1. Kris
    Kris
  2. Motzer
    Motzer
  3. Scher
    Scher
  4. Saltz
    Saltz
  5. Schwartz
    Schwartz
  6. Hudis
    Hudis
  7. Kelsen
    Kelsen
  8. Rosen
    Rosen
  9. Marks
    Marks
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)
  7. Sloan Kettering Institute Faculty (227)
  8. Hematologic Malignancies, Division of (224)
  9. Genitourinary Oncology Service (203)
  10. Molecular Pharmacology and Chemistry Program Faculty (172)
  1. "antineoplastic agents"
Formats
  1. Journal Article (1901)
  2. Review (47)
  3. Conference Paper (23)
  4. Editorial (7)
  5. Research Letter (6)
  6. Guidelines (4)
  7. Book Section (3)
  8. Correspondence (2)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)

More Groups

People
  1. Mark Kris (77)
  2. Robert Motzer (70)
  3. Howard Scher (58)
  4. Gary Schwartz (52)
  5. Leonard Saltz (52)
  6. Ting-Chao Chou (50)

More People

Years
  1. 2025 (16)
  2. 2024 (65)
  3. 2023 (49)
  4. 2022 (49)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (114)
  2. Journal of Clinical Oncology (111)
  3. Cancer (70)
  4. Seminars in Oncology (51)
  5. New England Journal of Medicine (43)
  6. Cancer Research (40)

More Publications

Publishers
  1. Elsevier Inc. (240)
  2. American Association for Cancer Research (187)
  3. Springer (175)
  4. American Society of Clinical Oncology (129)
  5. Wiley Blackwell (112)
  6. Nature Publishing Group (92)

More Publishers

Results (1995)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
    Journal Article

    Chakravarty, D.; Santos, E.; Ryder, M.; Knauf, J. A.; Liao, X. H.; West, B. L.; Bollag, G.; Kolesnick, R.; Thin, T. H.; Rosen, N.; more...
    Journal of Clinical Investigation (2011)

    Fulltext@MSK | Save
  • Treatment of locally recurrent mucosal melanoma with topical imiquimod
    Journal Article

    Smyth, E. C.; Flavin, M.; Pulitzer, M. P.; Gardner, G. J.; Costantino, P. D.; Chi, D. S.; Bogatch, K.; Chapman, P. B.; Wolchok, J. D.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
    Journal Article

    Shree, T.; Olson, O. C.; Elie, B. T.; Kester, J. C.; Garfall, A. L.; Simpson, K.; Bell-Mcguinn, K. M.; Zabor, E. C.; Brogi, E.; Joyce, J. A.
    Genes and Development (2011)

    Fulltext@MSK | Save
  • Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): A randomised phase 3 trial
    Journal Article

    Rini, B. I.; Escudier, B.; Tomczak, P.; Kaprin, A.; Szczylik, C.; Hutson, T. E.; Michaelson, M. D.; Gorbunova, V. A.; Gore, M. E.; Rusakov, I. G.; more...
    Lancet (2011)

    Fulltext@MSK | Save
  • A phase i trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma
    Journal Article

    Nghiemphu, P. L.; Wen, P. Y.; Lamborn, K. R.; Drappatz, J.; Robins, H. I.; Fink, K.; Malkin, M. G.; Lieberman, F. S.; Deangelis, L. M.; Torres-Trejo, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib
    Journal Article

    Sharma, M.; Ravandi, F.; Bayraktar, U. D.; Chiattone, A.; Bashir, Q.; Giralt, S.; Chen, J.; Qazilbash, M.; Kebriaei, P.; Konopleva, M.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • The "sWOT" of BRAF inhibition in melanoma: RAF inhibitors, MEK inhibitors or both?
    Journal Article

    Nissan, M. H.; Solit, D. B.
    Current Oncology Reports (2011)

    Fulltext@MSK | Save
  • No place like home? Outpatient management of patients with febrile neutropenia and low risk
    Journal Article

    Freifeld, A. G.; Sepkowitz, K. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • NCCN biosimilars white paper: Regulatory, scientific, and patient safety perspectives
    Journal Article

    Zelenetz, A. D.; Ahmed, I.; Braud, E. L.; Cross, J. D.; Davenport-Ennis, N.; Dickinson, B. D.; Goldberg, S. E.; Gottlieb, S.; Johnson, P. E.; Lyman, G. H.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • Erythematous patches and plaques on the chest with induration of the breasts
    Journal Article

    Balagula, Y.; Lopez, N. J.; Busam, K. J.; Quigley, E. A.
    Archives of Dermatology (2011)

    Fulltext@MSK | Save